CSIMarket Company Name, Ticker, Suppliers, else..


Prothena Corporation Public Limited Company  (PRTA)
Other Ticker:  
 

Prothena Corporation Public Limited Company

PRTA's Fundamental analysis



Looking into Prothena Public Limited growth rates, revenue grew by 3184.75 % in II. Quarter 2024 from the same quarter a year ago. Ranking at No. 917

Major Pharmaceutical Preparations industry recorded growth of revenues by 5.17 %

Prothena Public Limited realized net income compared to net loss a year ago in II. Quarter 2024

• More on PRTA's Growth


Prothena Public Limited
realized a net loss in trailing twelve months.

Prothena Public Limited realized cash reduction of $ -2.68 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.39.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.76.


• More on PRTA's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,180,685
 Net Income/Employee (TTM) $ -276,750
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 10.57

Prothena Public Limited
realized net loss in trailing twelve months.

Prothena Public Limited realized cash outflow of $ -2.68per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.39.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.76.

Prothena Public Limited Price to Book Ratio is at 1.64 lower than Industry Avg. of 85.03. and higher than S&P 500 Avg. of 0

• More on PRTA's Valuation

•  Market Capitalization (Millions $) 953
•  Shares Outstanding (Millions) 55
•  Employees 184
•  Revenues (TTM) (Millions $) 217
•  Net Income (TTM) (Millions $) -51
•  Cash Flow (TTM) (Millions $) -148
•  Capital Exp. (TTM) (Millions $) -3
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 1,180,685
•  Net Income/Employee(TTM) $ -276,750
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 10.57

•  Market Capitalization (Millions $) 953
•  Shares Outstanding (Millions) 55
•  Employees 184
•  Revenues (TTM) (Millions $) 217
•  Net Income (TTM) (Millions $) -51
•  Cash Flow (TTM) (Millions $) -148
•  Capital Exp. (TTM) (Millions $) -3


    PRTA's Profitability Comparisons
Prothena Public Limited achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in II. Quarter 2024 to 44.22 %.

Prothena Public Limited net profit margin of 50.67 % is currently ranking no. 11 in Major Pharmaceutical Preparations industry, ranking no. 20 in Healthcare sector and number 133 in S&P 500.


Profitability by Segment
Total 50.67 %



  Ratio
•   Capital Ratio (MRQ) 12.54
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.11
•  Asset Turnover Ratio (TTM) 0.33
•  Inventory Turnover Ratio (TTM) -



Prothena Public Limited achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in II. Quarter 2024 to 44.22 %.

Prothena Public Limited net profit margin of 50.67 % is currently ranking no. 11 in Major Pharmaceutical Preparations industry, ranking no. 20 in Healthcare sector and number 133 in S&P 500.

• More on PRTA's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com